A potential new therapeutic use for anti-HIV drugs known as protease inhibitors has been suggested by a team of researchers from Harvard Medical School, Boston, and Inserm U848, France, as a result of their work in a mouse model of retinal detachment.
An important cause of vision loss in many diseases of the eye is the death (by a process known as apoptosis) of nerve cells in the eye (known as photoreceptors) after retinal detachment. In the study, administration of HIV protease inhibitors by mouth markedly decreased photoreceptor apoptosis in the mouse model of retinal detachment.
Mechanistic analysis in mouse retinal cell cultures and in mice expressing decreased amounts of specific proteins established that the HIV protease inhibitors disrupted two molecular pathways that cause apoptotic cell death, both of which affect the cell compartments known as mitochondria.
As the same apoptotic cell death–inducing pathways were shown to be activated in human retinas after retinal detachment, the authors suggest that although the HIV protease inhibitors cannot reattach the retina, they might be of clinical benefit through their ability to prevent the photoreceptor apoptosis that has a central role in vision loss after retinal detachment.
Citation: Joan W. Miller, HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice,
Journal of Clinical Investigation 2008 (
https://www.the-jci.org/article.php?id=34267)
Source: Journal of Clinical Investigation
Related stories:
First gene associated with dry macular degeneration found
In a study that underscores the important role that individual genetic profiles will play in the development of new therapies for disease, a multi-institutional research team – led by Kang Zhang, MD, PhD professor of ophthalmology and human genetics at Shiley Eye Center at the University of California, San Diego, School of Medicine – has made two important discoveries related to age-related macular degeneration (AMD), the leading cause of blindness in adults over the age of 60.
New discovery may improve treatment of one of the world's leading causes of blindness
An inflammatory eye condition that is one of the world’s leading causes of blindness could be treated much more effectively and easily thanks to a new discovery here.
Medication slows progression of myopia in children
Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the
Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Coatings to help medical implants connect with neurons
Plastic coatings could someday help neural implants treat conditions as diverse as Parkinson's disease and macular degeneration.
Scientists identify critical protein complex in formation of cell cilia
An international team led by NYU Cancer Institute have identified a protein complex that regulates the formation of cilia, which are found on virtually all mature human cells and are essential to normal cell function.
Cells in eye could help control sleep
(PhysOrg.com) -- A set of nerve cells in the eye control our levels of sleepiness according to the brightness of our surroundings, Oxford University researchers have discovered. The cells directly regulate the activity of sleep centres in the brain, providing a new target for the development of drugs to control sleep and alertness.
Stretchable silicon camera next step to artificial retina
(PhysOrg.com) -- By combining stretchable optoelectronics and biologically inspired design, scientists have created a remarkable imaging device, with a layout based on the human eye.
Protein transports nutrients believed to protect against eye disease
Scientists have identified the protein responsible for transporting nutrients to the eye that are believed to protect against the development of age-related macular degeneration, a leading cause of vision loss in elderly Americans.